• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A prognostic score in histological node negative breast cancer.组织学检查淋巴结阴性乳腺癌的预后评分
Br J Cancer. 1990 Mar;61(3):436-40. doi: 10.1038/bjc.1990.96.
2
[What are the prognostic factors in operable breast cancer without histologic axillary lymph node invasiveness. Results of an uni- and multifactorial analysis].[无组织学腋窝淋巴结浸润的可手术乳腺癌的预后因素。单因素和多因素分析结果]
Bull Cancer. 1989;76(1):51-60.
3
Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis.
Cancer. 1988 Dec 15;62(12):2517-24. doi: 10.1002/1097-0142(19881215)62:12<2517::aid-cncr2820621211>3.0.co;2-9.
4
[Lobular invasive breast cancer prognostic factors: About 940 patients].小叶浸润性乳腺癌的预后因素:约940例患者
Gynecol Obstet Fertil. 2015 Nov;43(11):712-7. doi: 10.1016/j.gyobfe.2015.09.007. Epub 2015 Oct 16.
5
Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.腋窝淋巴结转移阳性率可预测非转移性乳腺癌患者的生存率。
Acta Oncol. 2008;47(2):232-8. doi: 10.1080/02841860701678761.
6
[Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].基于真实世界数据的1791例保乳手术治疗乳腺癌患者的预后及危险因素
Zhonghua Zhong Liu Za Zhi. 2018 Aug 23;40(8):619-625. doi: 10.3760/cma.j.issn.0253-3766.2018.08.011.
7
C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.马来西亚国民大学医学中心乳腺癌中C-erbB-2癌蛋白表达:与肿瘤特征及短期生存的关系
Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):663-70.
8
Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.雌激素受体阳性、人表皮生长因子受体2阴性乳腺癌的淋巴结转移灶中孕激素受体表达缺失与他莫昔芬治疗后复发相关。
J Clin Pathol. 2017 Nov;70(11):954-960. doi: 10.1136/jclinpath-2016-204304. Epub 2017 Apr 17.
9
[Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].腹股沟淋巴结转移乳腺癌患者的临床病理特征及预后因素:附17例报告
Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):207-11. doi: 10.3760/cma.j.issn.0253-3766.2013.03.010.
10
TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.TIF1γ干扰TGFβ1/SMAD4信号传导,从而导致可手术乳腺癌患者预后不良。
BMC Cancer. 2015 Jun 4;15:453. doi: 10.1186/s12885-015-1471-y.

引用本文的文献

1
Identifying accessible prognostic factors for breast cancer relapse: a case-study on 405 histologically confirmed node-negative patients.确定乳腺癌复发的可及预后因素:对 405 例组织学确认的淋巴结阴性患者的病例研究。
World J Surg Oncol. 2017 Nov 23;15(1):206. doi: 10.1186/s12957-017-1272-7.
2
Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.一种用于预测接受手术作为首要干预措施的乳腺癌患者疾病特异性生存的新型分期系统:是时候修改当前的美国癌症联合委员会分期系统了。
J Clin Oncol. 2011 Dec 10;29(35):4654-61. doi: 10.1200/JCO.2011.38.3174. Epub 2011 Nov 14.
3
Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution.乳腺癌的预后因素:诺丁汉预后指数在单一机构接受治疗患者中的价值。
Surg Today. 2005;35(11):907-11. doi: 10.1007/s00595-005-3056-x.
4
Role of age as a prognostic factor in breast cancer.年龄作为乳腺癌预后因素的作用。
Surg Today. 1997;27(3):213-6. doi: 10.1007/BF00941647.
5
Monoclonal antibody BrE-3 participation in a multivariate prognostic model for infiltrating ductal carcinoma of the breast.
Breast Cancer Res Treat. 1994;30(3):243-61. doi: 10.1007/BF00665966.
6
General surgery.普通外科
Postgrad Med J. 1991 Oct;67(792):876-91. doi: 10.1136/pgmj.67.792.876.
7
Steroid receptors in early breast cancer.早期乳腺癌中的类固醇受体
BMJ. 1992 Jul 4;305(6844):51. doi: 10.1136/bmj.305.6844.51-b.
8
The Nottingham Prognostic Index in primary breast cancer.原发性乳腺癌的诺丁汉预后指数
Breast Cancer Res Treat. 1992;22(3):207-19. doi: 10.1007/BF01840834.

本文引用的文献

1
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.乳腺癌的组织学分级与预后;对1409例病例的研究,其中359例已随访15年。
Br J Cancer. 1957 Sep;11(3):359-77. doi: 10.1038/bjc.1957.43.
2
Management and survival of female breast cancer: results of a national survey by the American College of Surgeons.女性乳腺癌的管理与生存情况:美国外科医师学会全国调查结果
Cancer. 1980 Jun 15;45(12):2917-24. doi: 10.1002/1097-0142(19800615)45:12<2917::aid-cncr2820451203>3.0.co;2-m.
3
Breast cancer without axillary metastases. Are there high-risk biologic subpopulations?无腋窝转移的乳腺癌。是否存在高风险生物学亚群?
Cancer. 1982 Nov 1;50(9):1820-7. doi: 10.1002/1097-0142(19821101)50:9<1820::aid-cncr2820500928>3.0.co;2-s.
4
A prognostic index in primary breast cancer.原发性乳腺癌的预后指数
Br J Cancer. 1982 Mar;45(3):361-6. doi: 10.1038/bjc.1982.62.
5
Progesterone and estrogen receptors as prognostic variables in breast cancer.孕激素和雌激素受体作为乳腺癌的预后变量
Cancer Res. 1983 Jun;43(6):2985-90.
6
The long-term prognostic significance of the thymidine labelling index in breast cancer.乳腺癌中胸苷标记指数的长期预后意义。
Int J Cancer. 1984 Apr 15;33(4):441-5. doi: 10.1002/ijc.2910330404.
7
Prognostic factors and tumour markers in early breast cancer; a commentary.早期乳腺癌的预后因素和肿瘤标志物;一篇评论
Eur J Cancer Clin Oncol. 1983 Dec;19(12):1693-7. doi: 10.1016/0277-5379(83)90154-2.
8
Progesterone receptors as a prognostic factor in Stage II breast cancer.孕激素受体作为II期乳腺癌的一个预后因素
N Engl J Med. 1983 Dec 1;309(22):1343-7. doi: 10.1056/nejm198312013092240.
9
Prognostic factors in patients with stage I, estrogen receptor-negative carcinoma of the breast. A clinicopathologic study.I期雌激素受体阴性乳腺癌患者的预后因素。一项临床病理研究。
Cancer. 1983 Oct 15;52(8):1423-31. doi: 10.1002/1097-0142(19831015)52:8<1423::aid-cncr2820520815>3.0.co;2-o.
10
Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading.雌激素受体状态在乳腺癌中与肿瘤分期、腋窝淋巴结转移及组织病理学分级相关的预后意义。
Cancer. 1984 Nov 15;54(10):2237-42. doi: 10.1002/1097-0142(19841115)54:10<2237::aid-cncr2820541029>3.0.co;2-v.

组织学检查淋巴结阴性乳腺癌的预后评分

A prognostic score in histological node negative breast cancer.

作者信息

Chevallier B, Mosseri V, Dauce J P, Bastit P, Julien J P, Asselain B

机构信息

Service de Médecine Intene et chimiothérapie, Centre H. Becquerel, Rouen, France.

出版信息

Br J Cancer. 1990 Mar;61(3):436-40. doi: 10.1038/bjc.1990.96.

DOI:10.1038/bjc.1990.96
PMID:2328212
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1971289/
Abstract

Between October 1977 and December 1983, 379 consecutive patients have been treated for unilateral, non-metastatic breast cancer, either with conservative (n = 205) or radical surgery (n = 174), with axillary dissection in all the cases. None of them had histologically proved lymph node involvement. Oestrogen receptor (ER) and progesterone receptor (PR) levels were measured on each tumour. Levels greater than 5 fmol mg-1 cytosolic protein were considered as positive for both ER and PR. At 5 years, overall survival (OS) and disease-free survival (DFS) are respectively 88% and 78%. Unifactorial analysis using Kaplan and Meier estimates and the log rank test revealed that OS was significantly related to age (P less than 0.05), tumour size (P less than 0.001), histological grading (SBR) (P less than 0.01), ER (P less than 0.001) and PR (P less than 0.001). DFS was significantly related to the same factors. Menopausal status, number of breast tumour foci and previous familial history of breast cancer were not significant. Multifactorial analysis revealed that DFS was significantly related to age (bad prognosis (b.p.) less than or equal to 37 years old), tumour size and histological grading (b.p. SBR = 3), and that OS was significantly related to tumour size and PR (b.p. PR less than or equal to 5 fmol mg-1 protein). A prognostic score has been constructed for both DFS and OS. These scores divide our patients into three significantly different (P less than 0.0001) groups with good, intermediate and bad prognosis.

摘要

1977年10月至1983年12月期间,379例连续性单侧非转移性乳腺癌患者接受了治疗,其中205例行保乳手术,174例行根治性手术,所有病例均进行了腋窝淋巴结清扫。所有患者均无组织学证实的淋巴结受累。对每个肿瘤均检测了雌激素受体(ER)和孕激素受体(PR)水平。ER和PR水平大于5 fmol mg-1胞浆蛋白被视为阳性。5年时,总生存率(OS)和无病生存率(DFS)分别为88%和78%。采用Kaplan-Meier估计法和对数秩检验进行单因素分析显示,OS与年龄(P<0.05)、肿瘤大小(P<0.001)、组织学分级(SBR)(P<0.01)、ER(P<0.001)和PR(P<0.001)显著相关。DFS与相同因素显著相关。绝经状态、乳腺肿瘤灶数量和既往乳腺癌家族史无显著意义。多因素分析显示,DFS与年龄(预后不良(b.p.)≤37岁)、肿瘤大小和组织学分级(b.p. SBR=3)显著相关,而OS与肿瘤大小和PR(b.p. PR≤5 fmol mg-1蛋白)显著相关。已构建了DFS和OS的预后评分。这些评分将我们的患者分为预后良好、中等和不良的三个显著不同(P<0.0001)的组。